Argenx Builds Momentum on Strong Execution and Expanding Indications
March 02, 2026
Phipps, Matt
Balancing Stable Anchor Positions With Best-Of-Breed Innovators
September 21, 2025
Reddy, Sunil
Spotting Potential in the High-Risk, High Reward Neuroscience Space
October 20, 2024
Beatty, Joel
New Drug Trials Spur Continued Interest in Anti-Obesity Space
October 20, 2024
Phipps, Matt
Next-Generation Immune-Oncology Drugs Show Early Promise
March 30, 2023
Phipps, Matt
Pricing Restrictions, Economic Concerns Weigh on Biotech Sector
March 30, 2023
Nierengarten, David
Biotechs Hit Bottom and Bounce Back — Twice
August 18, 2022
Nierengarten, David
Slowing of Clinic Trial Data Hampers Early-Stage Biotechs
March 18, 2022
Nierengarten, David
Low Cost of Capital Sets Stage for Uptick in Biotech M&A
March 18, 2021
Nierengarten, David
Seeing a Bifurcation of Therapeutic Focus in the Oncology Space
September 30, 2020
Nierengarten, David
